Glaxosmithkline Share News (GSK)

Glaxosmithkline Information

Buy GSK Shares
Add GSK to Watchlist
Add GSK to Alert

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 1,733.50

Bid: 1,732.50

Ask: 1,733.00

Change: 5.00 (0.29%)

Spread: 0.50 (0.029%)

Open: 1,733.00

High: 1,739.50

Low: 1,724.50

Prev. Close: 1,728.50

Last checked at -

UK BROKER RATINGS SUMMARY: UBS High On Glaxo, Deutsche Down On Aviva

Thu, 21st Nov 2019 09:38

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday afternoon:

----------

FTSE 100

----------

DEUTSCHE BANK CUTS AVIVA TO 'HOLD' ('BUY') - TARGET 450 (485) PENCE

----------

UBS RAISES GLAXOSMITHKLINE TO 'BUY' (NEUTRAL) - PRICE TARGET 1900 (1610) PENCE

----------

CITIGROUP INITIATES SMITH & NEPHEW WITH 'BUY'

----------

CITIGROUP RAISES MELROSE INDUSTRIES PRICE TARGET TO 255 (230) PENCE - 'BUY'

----------

GOLDMAN SACHS INITIATES JD SPORTS FASHION WITH 'BUY' - TARGET 870 PENCE

----------

GOLDMAN SACHS CUTS DCC PRICE TARGET TO 7500 (7900) PENCE - 'NEUTRAL'

----------

GOLDMAN SACHS CUTS INFORMA PRICE TARGET TO 690 (723) PENCE - 'SELL'

----------

UBS CUTS PEARSON PRICE TARGET TO 880 (900) PENCE - 'BUY'

----------

SOCIETE GENERALE RAISES SAGE GROUP PRICE TARGET TO 590 (536) PENCE - 'SELL'

----------

SOCIETE GENERALE CUTS KINGFISHER PRICE TARGET TO 170 (184) PENCE - 'SELL'

----------

PEEL HUNT RAISES WHITBREAD PRICE TARGET TO 5200 (4800) PENCE - 'BUY'

----------

FTSE 250

----------

HSBC CUTS HAYS TO 'HOLD' ('BUY') - TARGET 155 (180) PENCE

----------

CITIGROUP CUTS MITCHELLS & BUTLERS TO 'NEUTRAL' ('BUY') - TARGET 490 (440) PENCE

----------

MORGAN STANLEY CUTS MITCHELLS & BUTLERS TO 'EQUAL-WEIGHT' ('OVERWEIGHT') - TARGET 450(430) PENCE

----------

LIBERUM RAISES MITCHELLS & BUTLERS PRICE TARGET TO 600 (430) PENCE - 'BUY'

----------

PEEL HUNT CUTS SENIOR TO 'HOLD' ('BUY') - TARGET 175 (215) PENCE

----------

DEUTSCHE BANK INITIATES TRAVIS PERKINS WITH 'HOLD' - TARGET 1550 PENCE

----------

COMMERZBANK RAISES EASYJET PRICE TARGET TO 1450 (1150) PENCE - 'HOLD'

----------

JPMORGAN RAISES INTERMEDIATE CAPITAL TARGET TO 1720 (1635) PENCE - 'OVERWEIGHT'

----------

BERENBERG RAISES DOMINO'S PIZZA PRICE TARGET TO 225 (200) PENCE - 'SELL'

----------

BARCLAYS CUTS JOHN WOOD GROUP PRICE TARGET TO 450 (600) PENCE - 'UNDERWEIGHT'

----------

GOLDMAN CUTS TULLOW OIL PLC PRICE TARGET TO 183 (326.6) PENCE - 'BUY'

----------

OTHER MAIN MARKET AND AIM

----------

BARCLAYS INITIATES C&C GROUP WITH 'UNDERWEIGHT' - TARGET 310 PENCE

----------

PEEL HUNT INITIATES PREMIER FOODS WITH 'BUY' - TARGET 50 PENCE

----------

PEEL HUNT RAISES CHARLES STANLEY GROUP TO 'BUY' ('HOLD') - TARGET 300 (280) P

----------

JEFFERIES RAISES DART GROUP TO 'BUY' ('HOLD') - TARGET 1570 (900) PENCE

----------

DEUTSCHE BANK CUTS IQE PRICE TARGET TO 50 (64) PENCE - 'HOLD'

----------

DEUTSCHE BANK CUTS FEVERTREE DRINKS TO 'HOLD' ('BUY') - TARGET 2200 (2800) PENCE

----------

HSBC CUTS FEVERTREE DRINKS PRICE TARGET TO 3300 (3400) PENCE - 'BUY'

----------

JEFFERIES CUTS FEVERTREE DRINKS PRICE TARGET TO 2300 (2400) PENCE - 'HOLD'

----------

RBC CUTS FEVERTREE DRINKS PRICE TARGET TO 2200 (2500) PENCE - 'SECTOR PERFORM'

----------

RBC RAISES CMC MARKETS PRICE TARGET TO 145 (125) PENCE - 'OUTPERFORM'

----------

LIBERUM RAISES SPEEDY HIRE PRICE TARGET TO 80 (77) PENCE - 'BUY'

----------

More News

12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Latest Share Chat

Glaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: UBS High On Glaxo, Deutsche Down On Aviva

Login to your account

Quickpicks are a member only feature

Login to your account